Posted by Hugh on January 18, 2022, at 10:36:07
In reply to Re: Esmethadone helps treatment-resistant depression » Hugh, posted by beckett2 on January 17, 2022, at 21:34:02
> Any sense of when this might become available to the market? Thanks again for the information, Hugh.
You're welcome. Relmada Therapeutics, Inc. is currently recruiting for phase 3 clinical trials using REL-1017 (esmethadone) for major depressive disorder. If these trials are successful, REL-1017 should receive FDA approval a few years from now.
https://clinicaltrials.gov/ct2/results?cond=&term=REL-1017&cntry=&state=&city=&dist=
poster:Hugh
thread:1118094
URL: http://www.dr-bob.org/babble/20211102/msgs/1118200.html